Artemisinin Market Analysis 2026

Global Artemisinin Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Artemisinin Market Report Description

We have various report editions of Artemisinin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Artemisinin Market Insights Video

Competitive Landscape of the Artemisinin Market

In the artemisinin market's competitive landscape, numerous key competitors are driving innovation and growth. Major players, such as research and development, new product development, geographic expansion, and indication expansion, are pursuing a number of different marketing strategies. Global powerhouses produce the majority of medications, and industry leaders have established themselves in the market by increasing their investment in research and developing better distribution networks.

In November 2022, Novartis and Anti-Malaria Drugs Venture announced that it will proceed to Phase 3 research of a novel combination of ganaplacide/lumefantrine-SDF for treating malaria in adults and children. Unlike traditional artemisinin therapies, this regimen is designed to be administered once daily and targets resistant strains of malaria. (Source: https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-decision-move-phase-3-study-novel-ganaplacidelumefantrine-sdf-combination-adults-and-children-malaria) In April 2024, Fosun Pharma unveiled their second-generation injectable artesunate, which has a one-step preparation method, making administration easier and lowering treatment expenses for severe malaria. This novel formulation is especially beneficial in malaria-endemic areas like Africa, where access to medical care is limited. The medication was highlighted at the 2023 Pan-African Malaria Conference when its function in treating severe Plasmodium falciparum malaria was discussed. (Source: https://www.fosunpharma.com/en/content/details37_13124.html) In December 2022, According to the World Malaria Report 2022, the following regions experienced an increase in malaria cases in 2021: Comoros (56.9%), Costa Rica (52.4%), the Democratic People's Republic of Korea (22.8%), Ecuador (11.1%), Eswatini (53.9%), French Guyana (2.1%), Guatemala (16.9%), Honduras (47.4%), Panama (55.3%), and Sao Tome and Principe (28.9%). (Source: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022/questions-and-answers)

Top Companies Market Share in Artemisinin Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Artemisinin Market

Which Region Dominates the Artemisinine Market in 2024?

According to Cognitive Market Research, North America currently dominates the artemisinines market, and the region is expected to have significant growth during the projected period. This is due to the rising number of travelers to malaria-prone regions, which drives the demand for artemisinin-based therapies, particularly in the U.S. and Canada

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The large-scale cultivation of Artemisia annua and the region’s leading role in the production and export of Artemisinin, particularly from countries like China and Vietnam

The current report Scope analyzes Artemisinin Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Artemisinin Market Analysis

According to Cognitive Market Research, the global artemisinin market size was estimated at USD 65.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 26.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.7%from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the artemisinin market with a market size of USD 20.58 million in 2024 and is projected to grow at a CAGR of 17.5% during the forecast period. There is a demand for Artemisinin-based combination therapies (ACTs) due to travel-related malaria cases.
• The Canada artemisinin market had a market share of USD 3.13 million in 2024 and is projected to grow at a CAGR of 18.5% during the forecast period. the increasing demand for travel-related malaria treatments and ongoing research into its potential applications in cancer therapies
• The Mexico artemisinin market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 2.37 million in 2024.

Europe Artemisinin Market Analysis

According to Cognitive Market Research, the global artemisinin market size was estimated at USD 65.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 19.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031.

• The United Kingdom artemisinin market had a market share of USD 3.29 million in 2024 and is projected to grow at a CAGR of 18.8% during the forecast period. In the UK, artemisinin sales witness an upswing due to the focus on pharmaceutical research, particularly in the development of Artemisinin-based therapies for malaria treatment and the exploration of its potential in cancer therapies.
• The France artemisinin market is projected to witness growth at a CAGR of 17.2% during the forecast period, with a market size of USD 1.80 million in 2024.
• According to Cognitive Market Research, the German artemisinin market size was valued at USD 3.87 million in 2024 and is projected to grow at a CAGR of 18.2% during the forecast period. In Germany, artemisinin surged due to the country’s strong pharmaceutical industry and its focus on developing innovative antimalarial treatments.
• The Italy artemisinin market is projected to witness growth at a CAGR of 17.4% during the forecast period, with a market size of USD 1.68 million in 2024.
• The Russia artemisinin market is projected to witness growth at a CAGR of 17.0% during the forecast period, with a market size of USD 3.03 million in 2024.
• The Spain artemisinin market is projected to witness growth at a CAGR of 17.1% during the forecast period with a market size of USD 1.60 million in 2024
• The Luxembourg artemisinin market is projected to witness growth at a CAGR of 18.1% during the forecast period, with a market size of USD 0.61 million in 2024.
• The Portugal artemisinin market is projected to witness growth at a CAGR of 17.8% during the forecast period, with a market size of USD 0.41 million in 2024.
• The Greece artemisinin market is projected to witness growth at a CAGR of 18.3% during the forecast period, with a market size of USD 0.23 million in 2024.
• The Rest of Europe's artemisinin market is projected to witness growth at a CAGR of 16.7% during the forecast period, with a market size of USD 3.03 million in 2024.

Asia Pacific Artemisinin Market Analysis

According to Cognitive Market Research, the global artemisinin market size was estimated at USD 65.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 15.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.5% from 2024 to 2031.

• According to Cognitive Market Research, the China artemisinin market size was valued at USD 6.75 million in 2024 and is projected to grow at a CAGR of 21.0% during the forecast period. Artemisinin surged in China due to advanced biotechnological processes and strong government initiatives.
• The Japan artemisinin market is projected to witness growth at a CAGR of 20.0% during the forecast period, with a market size of USD 2.07 million in 2024.
• The India artemisinin market had a market share of USD 1.80 million in 2024 and is projected to grow at a CAGR of 23.3% during the forecast period. The country's expanding pharmaceutical sector is increasing the production and export of Artemisinin-based combination therapies.
• The South Korean artemisinin market is projected to witness growth at a CAGR of 20.6% during the forecast period, with a market size of USD 1.50 million in 2024.
• The Australian artemisinin market is projected to witness growth at a CAGR of 21.2% during the forecast period, with a market size of USD 0.78 million in 2024.
• The South East Asia artemisinin market is projected to witness growth at a CAGR of 22.5% during the forecast period, with a market size of USD 1.03 million in 2024.
• The Rest of Asia Pacific artemisinin market is projected to witness growth at a CAGR of 21.3% during the forecast period, with a market size of USD 1.06 million in 2024.

South America Artemisinin Market Analysis

According to Cognitive Market Research, the global artemisinin market size was estimated at USD 65.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 3.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil artemisinin market size was valued at USD 1.40 million in 2024 and is projected to grow at a CAGR of 19.5% during the forecast period. artemisinin flourished in Brazil due to the country's focus on controlling malaria in the Amazon region.
• Argentina's artemisinin market had a market share of USD 0.55 million in 2024 and is projected to grow at a CAGR of 19.8% during the forecast period. Government health initiatives aimed at improving awareness and prevention of malaria in susceptible populations further support the demand.
• Colombia artemisinin market is projected to witness growth at a CAGR of 18.7% during the forecast period, with a market size of USD 0.29 million in 2024.
• Peru artemisinin market is projected to witness growth at a CAGR of 19.1% during the forecast period, with a market size of USD 0.27 million in 2024.
• Chile artemisinin market is projected to witness growth at a CAGR of 19.2% during the forecast period, with a market size of USD 0.23 million in 2024.
• The Rest of Latin America's artemisinin market is projected to witness growth at a CAGR of 18.0% during the forecast period, with a market size of USD 0.52 million in 2024.

Middle East Artemisinin Market Analysis

According to Cognitive Market Research, the global artemisinin market size was estimated at USD 65.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 1.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031..

• The GCC Countries artemisinin market is projected to witness growth at a CAGR of 20.0% during the forecast period, with a market size of USD 0.56 million in 2024. Artemisinin sales flourish due to travel-related malaria cases, as the region is not endemic to malaria.
• The Egypt artemisinin market is projected to witness growth at a CAGR of 19.5% during the forecast period, with a market size of USD 0.14 million in 2024.
• The South Africa artemisinin market is projected to witness growth at a CAGR of 20.2% during the forecast period, with a market size of USD 0.21 million in 2024. Artemisinin sales flourished in South Africa due to rising demand for Artemisinin-based combination therapies.
• The Turkey artemisinin market is projected to witness growth at a CAGR of 18.7% during the forecast period, with a market size of USD 0.11 million in 2024.
• The Nigeria artemisinin market is projected to witness growth at a CAGR of 18.3% during the forecast period, with a market size of USD 0.14 million in 2024.
• The Rest of the MEA artemisinin market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 0.15 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.